Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
116.11
+3.27 (2.89%)
Aug 12, 2026, 1:46 PM EDT - Market open

Rhythm Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-205.35-196.54-260.6-184.68-181.12-69.61
Depreciation & Amortization
1.081.341.561.761.671.16
Stock-Based Compensation
87.2366.8239.6832.5519.8320.8
Other Adjustments
15.1913.6894.99.43.6-100.25
Change in Receivables
-14.75-7.57-3.65-8.64-5.2-1.25
Changes in Inventories
-12.81-7.47-10.12-5.71-2.81-0.01
Changes in Accounts Payable
23.1121.8921.9214.771.5418.31
Changes in Unearned Revenue
--1.09--0.15-6.61-
Changes in Other Operating Activities
0.51-6.722.424.53-4.34-15.15
Operating Cash Flow
-105.35-115.68-113.88-136.16-173.43-146
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
--0.95--0.05-0.28-0.43
Purchases of Intangible Assets
--40-40.5-5.67-4-5
Purchases of Investments
-373.88-348.67-268.31-354.92-251.94-524.97
Proceeds from Sale of Investments
269.9252.47260.64354.97284.25361.25
Other Investing Activities
-----107
Investing Cash Flow
-144.94-137.15-48.17-5.6728.03-62.16

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
---24.3772.34-
Long-Term Debt Repaid
-22.17-19.92-12.9-7.4--
Net Long-Term Debt Issued (Repaid)
-22.17-19.92-12.916.9772.34-
Issuance of Common Stock
23.01237.8856.3957.4141.49166.48
Repurchase of Common Stock
-9.72-----
Net Common Stock Issued (Repurchased)
13.3237.8856.3957.4141.49166.48
Issuance of Preferred Stock
--138.85---
Net Preferred Stock Issued (Repurchased)
--138.85---
Other Financing Activities
--8.9---
Financing Cash Flow
179.79217.96191.2474.37213.83166.48

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.60.090-0.14--
Net Cash Flow
-69.9-34.7829.19-67.668.43-41.68

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-105.35-116.63-113.88-136.2-173.71-146.44
Free Cash Flow Growth
------
FCF Margin
-43.91%-61.46%-87.51%-175.91%-734.87%-4642.90%
Free Cash Flow Per Share
-1.56-1.79-1.87-2.36-3.33-2.95
Levered Free Cash Flow
-220.5-214.85-261.69-152.55-119.6-65.74
Unlevered Free Cash Flow
-189.79-185.52-250.07-169.76-189.98-166.19
SEC Filings: 10-K · 10-Q